Navigation Links
U.S. Genomics Awarded $9.1 Million Contract for Development of Advanced Biosensor by the U.S. Department of Homeland Security
Date:7/16/2008

WOBURN, Mass., July 16 /PRNewswire/ -- U.S. Genomics today announced the award of a $9.1 million contract by the U.S. Department of Homeland Security (DHS) Science and Technology Directorate. The Phase IIIX contract under the Bioagent Autonomous Networked Detectors (BAND) program will enable U.S. Genomics to continue development, testing and optimization of the company's sophisticated biological sensor for the detection of airborne pathogens using single molecule DNA mapping technology.

"The award of the Phase IIIX BAND contract further validates the potential of U.S. Genomics' single molecule based DNA mapping technology for use as a biological sensor," said John J. Canepa, Chief Executive Officer of U.S. Genomics; "The resources provided under the contract will allow us to perform extensive operational testing and to advance the capabilities of our prototype systems. These prototypes currently demonstrate the capabilities of our unique, proprietary approach to rapidly detect multiple bacterial pathogens, toxins and viruses simultaneously in an environmental sample using a single reagent set. U.S. Genomics continues to be excited about working with the outstanding team at The Department of Homeland Security Science and Technology Directorate to deliver a biosensor which meets the program's mandate to improve the security of our citizens. Additionally, our DNA mapping technology can be applied to multiple sample types for use in forensic, human diagnostic and military applications.

"U.S. Genomics' unique DNA mapping technology allows extremely precise "broadband" detection of bacterial pathogens, toxins and viruses in a biological sample. The technology's readings are sensitive to the single-molecule level and yield extremely low false positive rates. Using a universal reagent set that can detect and identify pathogens, the technology produces a genetic signature unique to each DNA fragment in the sample, and also identifies the organism from which the DNA originates. Unlike other detection technologies, U.S. Genomics' detection platform does not require amplification or the use of pathogen-specific reagents for detection of each threat organism, providing broad operational flexibility and lower costs. Furthermore, U.S. Genomics' approach has the potential to identify genetically modified species, such as those that may have been deliberately engineered to elude traditional detection methods. These factors enable greater protection in defense applications and are the foundation for new, advanced diagnostics in human infectious disease.

About U.S. Genomics, Inc.

U.S. Genomics is pioneering single molecule biology technologies for biodefense and diagnostics applications by combining advances in microfluidics, optical engineering, and novel labeling strategies. Using its DNA mapping technology, the Company is developing sophisticated biological sensors for the detection and identification of pathogens and biomarkers in the air, human serum and other biologically relevant materials. The Company's biodefense focus on airborne pathogens has been funded in part by contracts from the U.S. Department of Homeland Security Science and Technology Directorate. U.S. Genomics' portfolio of products will further a greater understanding of genetics and disease that can lead to more effective therapeutics, diagnostics, and biodefense applications. For more information, please visit http://www.usgenomics.com.


'/>"/>
SOURCE U.S. Genomics
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
2. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
3. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
4. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
5. WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of DNAPrint Genomics
6. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
7. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
8. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
9. BioNanoatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome
10. BioNanomatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome
11. Rosetta Genomics to Host and Webcast its R&D Day on Friday, October 26, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... New Jersey and ... Indegene ( http://www.indegene.com ... und marketingorientierten Lösungen für die Life-Science-Branche, Pharmaunternehmen ... ein bekannter weltweiter Anbieter von innovativen wissenschaftlichen ... Zuge des Starts von IntraScience heute den ...
(Date:5/26/2016)... 2016 Q BioMed Inc. (OTCQB: QBIO), ... a featured presenter at the 5th Annual Marcum MicroCap Conference ... City at the Grand Hyatt Hotel. ... Inc. CEO, is scheduled to begin at 11a.m ET in ... strategy, recent developments and outline milestones for the balance of ...
(Date:5/26/2016)... ... 26, 2016 , ... FireflySci has been manufacturing quartz and ... over the globe. Their cute firefly logo has been spreading to more and ... spectrophotometer calibration standards that never require recalibration. These revolutionary standards have changed ...
(Date:5/25/2016)... , ... May 25, 2016 , ... ... Fitzmaurice recently became double board-certified in surgery and surgery of the hand by ... Fitzmaurice is no stranger to going above and beyond in his pursuit of ...
Breaking Biology Technology:
(Date:3/21/2016)... Massachusetts , March 22, 2016 ... facial recognition with passcodes for superior security   ... ), a leading provider of secure digital communications services, ... their biometric technology and offer enterprise customers, particularly those ... secure facial recognition and voice authentication within a mobile ...
(Date:3/15/2016)... , March 15, 2016 Yissum ... , the technology-transfer company of the Hebrew University, announced ... of remote sensing technology of various human biological indicators. ... raising $2.0 million from private investors. ... based on the detection of electromagnetic emissions from sweat ...
(Date:3/11/2016)... PUNE, India , March 11, 2016 ... to a new market research report "Image Recognition Market ... by Application (Marketing and Advertising), by Deployment Type (On-Premises ... Global Forecast To 2022", published by MarketsandMarkets, the global ... in 2015 to USD 29.98 Billion by 2020, at ...
Breaking Biology News(10 mins):